A consolidated partnership to explore the future of health. Healthware Group to co-host Frontiers Health Global Hybrid Conference 2022
Navigating and shaping the next era of healthcare. That’s the reason why Frontiers Conferences and Healthware Group have been joining forces over the years, conceiving and delivering a completely novel and disruptive conference fruition.
Healthware Group enhances its commitment as a global player in the health innovation space by renewing the foundational alliance with Frontiers Health, for its seventh edition, taking place in person in the ingenious and resourceful city of Milan, Italy, and virtually on October 20-21, 2022.
As conference global co-host and main sponsor, working at the intersection of technology, life sciences, and communications, Healthware Group has been tapping into its truly transformational attitude and global reach to leverage Frontiers Health among one of the leading global health innovation events, shaping an evolving, committed, responsible and forward-looking ecosystem, that performs and delivers well beyond their periodic global gatherings.
Frontiers Health brings together international thought leaders, policymakers, key industry players, and companies at the epicenter of it all for a two-day deep dive into the ongoing challenges, strategic trends, and scalable solutions likely to impact healthcare.
In its third year as a hybrid physical-virtual conference, Frontiers Health will be striving to produce a highly refined and curated learning and networking experience for like-minded delegates coming together from across the world, while continuing to level up our partnership opportunities, which include customized breakout sessions, corporate events, discussion panels, innovation challenges, and more.
This year’s conference will explore guiding themes inspired by the most compelling topics, including digital therapeutics & medicine, digital care delivery, telehealth, digital transformation, cross-industry innovations, funding & scaling, health equity and access.